E. Bilgin Et Al. , "Predictors of drug retention and treatment response in axial spondyloarthritis patients treated with certolizumab: real-life results from the HURBIO registry," CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.38, no.4, pp.609-614, 2020
Bilgin, E. Et Al. 2020. Predictors of drug retention and treatment response in axial spondyloarthritis patients treated with certolizumab: real-life results from the HURBIO registry. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.38, no.4 , 609-614.
Bilgin, E., Farisogullari, B., Armagan, B., Sari, A., Yardimci, G. K., Bolek, E. C., ... Kilic, L.(2020). Predictors of drug retention and treatment response in axial spondyloarthritis patients treated with certolizumab: real-life results from the HURBIO registry. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.38, no.4, 609-614.
Bilgin, E. Et Al. "Predictors of drug retention and treatment response in axial spondyloarthritis patients treated with certolizumab: real-life results from the HURBIO registry," CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.38, no.4, 609-614, 2020
Bilgin, E. Et Al. "Predictors of drug retention and treatment response in axial spondyloarthritis patients treated with certolizumab: real-life results from the HURBIO registry." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.38, no.4, pp.609-614, 2020
Bilgin, E. Et Al. (2020) . "Predictors of drug retention and treatment response in axial spondyloarthritis patients treated with certolizumab: real-life results from the HURBIO registry." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.38, no.4, pp.609-614.
@article{article, author={E. Bilgin Et Al. }, title={Predictors of drug retention and treatment response in axial spondyloarthritis patients treated with certolizumab: real-life results from the HURBIO registry}, journal={CLINICAL AND EXPERIMENTAL RHEUMATOLOGY}, year=2020, pages={609-614} }